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                                                        INTRODUCTION
The detection of meconium-stained amniotic fluid during labour often causes anxiety in the delivery 
room because of its association with increased perinatal mortality and morbidity. However, experts 
continue to debate whether the risk of harm is associated with the meconium itself, or whether the 
overall risk is increased because of the underlying condition leading to the passage of meconium.
The obstetric literature is fraught with controversy and unanswered questions regarding the significance 
of meconium in the aminotic fluid and the appropriate management protocols that should be followed 
when it is discovered. It is believed by some medical experts that the passage of meconium is triggered 
by fetal stress, such as hypoxia or asphyxia, and that the presence of meconium in the fluid may be 
considered an indicator of fetal distress. Others point out that the presence of meconium in the amniotic 
fluid also may be a result of gastrointestinal maturity. Thus, the presence of meconium in the amniotic 
fluid is only one factor to be considered along with many variable and clinical markers that may help to 
explain the etiology and timing of irreversible brain damage. There are many variables and unanswered 
questions concerning the time it takes for meconium to initiate pathologic placental changes or to cause 
damage to umbilical cord vessels for meconium to be a useful marker to time brain injury.
MECONIUM
Meconium is a thick, odorless, blackish green material, first demonstrable in the fetal intestine during 
the third month of gestation.
It is a sterile mixture of water (75-95%), mucopolysaccharides (80% dry weight), gastrointestinal 
secretions (bile salts and pancreatic, liver enzymes), solids, (vernix caseosa, lanugo, and squamous 
cells), blood minerals and lipids (free fatty acids).It’s pH ranges from 5.5 to 7. Meconium first appears 
in the fetal ileum between 10 to 16 weeks of gestation1.
The term meconium is derived from ancient Greek word meconium-‘arion’, or opium like, from the 
Greek word ‘mekoni’ meaning poppy juice. Aristotle coined the term, because he believed that the 
substance induced fetal sleep1.
INCIDENCE
Meconium staining of amniotic fluid (MSAF) occurs in approximately 10% to 26% of all deliveries, 
with the highest rates reported from North America1-5. Although meconium appears in the intestine 
very early in gestation, MSAF rarely occurs before 38 weeks of gestation. Incidence of MSAF 
increases thereafter and approximately 30% of newborns have MSAF if born after 42 weeks of 
gestation1. Meconium stained liquor is rare in premature infants (<5 percent of preterm pregnancies); if 
it does occur, there may be an association with infection and chorioamnionitis. The incidence of 
meconium aspiration syndrome varies between 1 and 5 percent of all deliveries where there has been 
meconium stained liquor, with higher rates reported from North America compared to Europe1-3,5. 
There are a number of factors associated with an increased risk of developing meconium aspiration 
syndrome. These include lack of antenatal care, black race, male fetus, abnormal fetal heart rate 
monitoring, thick meconium, oligohydromnios, operative delivery, poor activity, pulse, grimace, 
appearance and respiration (APGAR) scores, no oropharyngeal suctioning and the presence of 
meconium in the trachea8.
ETIOLOGY
Many theories have been proposed to explain the passage of meconium in utero; however, the precise 
mechanisms remain unclear. The increased incidence of MSAF with advancing gestational age 
probably reflects the maturation of peristalsis in the fetal intestine1. Motilin, an intestinal peptide that 
stimulates contraction of the intestinal muscle, is in lower concentration in the intestine of premature 
Vs postterm infants. Umbilical cord motilin concentration is higher in infants who passed meconium 
than in infants with clear amniotic fluid. Intestinal parasympathetic innervation amd myelination also 
increase throughout gestation and may play a role in the increased incidence of passage of meconium in 
late gestation. Inutero passage of meconium is also associated with fetal asphyxia and decreased 
umbilical venous blood PO21.
Experimentally, intestinal ischemia produces a transient period of hyperperistalsis and relaxation of 
anal sphincter tone, leading to the passage of meconium. The fetal diving reflex, which shunts blood 
preferentially to the brain and heart and away from the visceral organs during hypoxia may enhance 
intestinal ischaemia6.
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Fig.1: Factors leading to Meconium passage
MSAF AND FETAL DISTRESS
Is meconium an independent marker of fetal distress ?
 Previously meconium passage was a sign of fetal death or impending death. Several modern studies 
have examined data collected around the time of birth to correlate meconium passage and fetal distress. 
Such data must be viewed cautiously because the association of events of labour and particularly of 
delivery does not necessarily represent the intrauterine environment at the time of meconium passage. 
For eg.Apgar score analysis to correlate fetal distress with meconium stained fluid is misleading 
because it is affected by tracheal intubation. For meconium to be an independent marker of fetal 
distress, infants with meconium staining would have adverse perinatal outcomes without other 
evidence of fetal compromise. This has not been found to be the case in all12.
   In general, the neonatal outcome is in no way different in meconium stained amniotic fluid and clear 
amniotic fluid in labours with similar FHR abnormalities like normal heart rate pattern, fetal 
tachycardia, decreased FHR variability and absence of acceleration.
Thus meconium is not an independent marker of fetal distress, but rather of an event like cord 
compression and often an environment such as decreased amniotic fluid that may predispose to or be a 
consequence of fetal compromise. Some fetuses with meconium stained fluid will be compromised but 
most will not. As Miller et al have stated the presence of meconium in the amniotic fluid without signs 
of fetal asphyxia is not a sign of fetal distress13.
MSAF found at the onset of labour reflects a previous event which may or may not have been hypoxia 
and so the significance of such a finding is not clear. Routine amnioscopy, amniocentesis or artificial 
rupture of membranes to observe the colour of liquor have been suggested and put into practice with 
varying degrees of enthusiasm. However, such screening methods have not been subjected to 
evaluation by prospective randomized controlled trials7.
Exactly why some babies suffer varying degrees of the meconium aspiration syndrome and others do 
not is unclear but two important observations, strongly associated with bad outcome, require mention.
(a). Thick, Viscid MSAF
(b). MSAF in the presence of an abnormal fetal heart rate pattern.
(a) Thick, Viscid MSAF
Thick MSAF implies that there  has been coexisting oligo-hydromnios, which in itself is 
associated with fetal compromise. When MSAF occurs in the post mature fetus and oligohydromnios 
supervenes, an often fatal combination seems to coexist18. The airways become inspissated with this 
tenuous material which cannot be easily cleared by the neonate and so any preexisting hypoxia appears 
exaggerated. MSAF and oligohydromnios is a particularly difficult clinical problem because the 
sparsity of fluid can mean that it may remain undetected until the baby is delivered. Extreme vigilance 
is therefore required in labouring patients thought to have no amniotic fluid.
b) MSAF in the presence of an abnormal fetal heart rate pattern
The presence of MSAF without an abnormal fetal heart rate pattern does not appear to jeopardize fetal 
outcome, but when late decelerations are present the risk of meconium aspiration seems to be enhanced 
and the neonatal outcome may be prejudiced18. 
INTRAPARTUM FETAL MONITORING
FHR MONITORING
Since the introduction of fetal heart auscultation in the early 19-th century by Evory Kennedy, the 
estimation of FHR has evolved considerably and became the main stay of intrapartum fetal monitoring. 
Continuous electronic FHR monitoring was introduced in the late 1960’s and since then has attained 
wide acceptance in clinical obstetrics. During the interpretation of FHR recording, a systematic 
approach should be used to assess the following aspects.
1. Baseline rate
2. Baseline variability
3. Presence of accelerations
4. Presence of decelerations and the type and severity.
A normal FHR trace is one with a baseline between 110 and 150 beats per minute showing good 
variability (more than 5bpm) with accelerations and no decelerations. In the presence of a normal FHR 
tracing, there is only a 2% chance for the fetus to be acidotic  (pH<7.20) and a 1% chance for it to have 
a 5 minute apgar score <7. A definitely ominous or pathological FHR trace is one with a baseline 
tachycardia (>150 beats/minute) with absent variability and repetitive late or variable decelerations. 
Other sinester patterns are prolonged severe bradycardia (<80 beats/minute) for >10 minutes or a 
sinusoidal pattern without accelerations5.
PREDICTIVE VALUE OF ABNORMAL CTG IN LABOUR
Using a low 5 minute Apgar score as a end point (Apgar<7), abnormal intrapartum FHR has a high 
negative predictive value of over 90%, but a low positive predictive value of about 30% . This means 
that a normal trace indicates a fetus that is not hypoxic, while an abnormal trace is associated with a 
large number of false positives5.
MECONIUM ASPIRATION
Meconium found below the vocal cords defines meconium aspiration syndrome. It occurs in 
approximately 35% of live births with MSAF or in approximately 4% of all livebirths1. Meconium 
aspiration syndrome describes a wide spectrum of respiratory disease, ranging from respiratory disease 
to severe disease and death despite mechanical ventilation. It typically presents as respiratory distress, 
tachypnea, prolonged expiratory phase and hypoxemia soon after birth in an infant heavily stained on 
the nails, hair and umbilical cord with meconium or born through thick meconium. Less severe 
meconium aspiration, typically of nonparticulate meconium, may present with the appearance of a 
pneumonitis with mild increased work of breathing or peaceful tachypnea reaching a peak at one to 
three days and resolving slowly over the first weeks of life9.
Aspiration of meconium into the distal airways can occur either antenatally or postnatally, but in the 
majority of the affected infants, the exact timing is not clear. It leads to inflammation of pulmonary 
tissues and hypoxia. There is also evidence that the free fatty acids in meconium strip away alveolar 
surfactant9. In severe cases, the pathological progresses  to persistent pulmonary hypertension, other 
morbidity and death. Even with prompt and appropriate therapy, seriously affected infants frequently 
die or suffer long-term neurological sequelae.
PATHO PHYSIOLOGY
The quantity of meconium will affect the appearance and viscosity of the amniotic fluid, which ranges 
from a green tinged, thin meconium stained fluid to one with a thick, pea soup consistency1. Meconium 
in the amniotic fluid may stain the umbilical cord, placenta and fetus. The time from passage of 
meconium to delivery of the infant can possibly be estimated from the depth of penetration of 
meconium pigment into the placental membranes with subsequent uptake by placental macrophages.
Under normal circumstances fetal respiration is associated with movement of fluid from the airways 
out into the amniotic fluid. When fetal distress is present gasping may be initiated in utero. Under these 
circumstances amniotic fluid and particulate matter contained therein may be inhaled into the large 
airways. It may be present in the trachea or larger bronchi and may result in airways obstruction at 
delivery8. Meconium and squames may be found as far as alveoli in stillborn infants, and it is now 
widely recognized that meconium aspiration may occur antenatally. After airbreathing has commenced, 
especially if accompanied by gasping respirations, there is a rapid distal migration of meconium within 
the lung.
Pathophysiologically, the pulmonary problems are due to airway obstruction and a ball value 
phenomenon created by the presence of meconium within the airways. Areas of atelectasis develop 
within the lung, resulting from total small airway obstruction, adjacent to areas overexpansion from gas 
trapping in regions with partial obstruction2. Airleaks, including pneumomediastinum and 
pneumothorax, are more likely to occur after aspiration of meconium and cellular debris. Chemical 
inflammation secondary to aspirated meconium presumably leads to pneumonitis. There is also a 
concentration – dependent inhibition of surfactant by meconium, all of which could aggravate 
atelectasis, hypoventilation and intrapulmonary shunting. PPHN can be a major clinical problem in 
infants with meconium aspiration. The etiology of increase in pulmonary vascular resistance is some 
what controversial. Hypoxic pulmonary arterial vasoconstriction is most likely a major attributing 
factors.
Postmortem examination of lungs from infants with severe MAS reveals meconium, vernix, fetal 
squamous cells and cellular debris in the air spaces from the airways to the alveoli. An inflammatory 
response with polymorphonuclear leukocytes, macrophages, and alveolar edema maybe observed, but 
large quantities of meconium may be present without histologic signs of inflammation. Hyaline 
membrane  formation, pulmonary hemorrhage, and necrosis of pulmonary microvasculature and 
parenchyma can occur. Platelet rich microthrombi in small arteries and increased muscularization of 
distal arterioles have been described in some infants during of MAS.
DIAGRAM OF PATHOPHYSIOLOGY2: 
CLINICAL FEATURES
GENERAL APPEARANCE
The baby is usually mature or post mature, with long fingernails and a dry skin which soon starts to 
flake. The skin, nails and umbilical cord are often stained greenish yellow. The baby is not usually 
febrile, unless secondarily infected.
RESPIRATORY: 
The infant has tachypnea, which may exceed 120/mt. Because he is mature with firm rib cage, marked 
sternal retraction as seen in preterm neonates with RDS is rare, but intercostals and subcostal recession, 
the use of accessory muscles and flaring of the nostrils are usually present. An expiratory grunt may be 
heard. The meconium in the airways causes widespread sticky crepitations and occasional rhonchi, 
airtrapping and an over distended chest with an increased antero posterior diameter. The baby may 
remain symptomatic for only 24hrs, or he may be very dyspnoic for 7 – 10 days before recovery18.
CARDIOVASCULAR
In the absence of asphyxial damage to the myocardium there are no specific cardiovascular features of 
MAS. Hypotension suggests myocardial damage, as do signs of congestive heart failure. In 
uncomplicated MAS the heart tends to be around 110-125/min and the blood pressure is maintained 
within normal range. If  PPHN develops S2 may remain single and there may be the murmur of 
tricuspid incompetence18.
CENTRAL NERVOUS SYSTEM
Depending on the severity of the coexisiting neurological insults the baby may behave normally or 
show any of the neurological features of birth asphyxia, ranging from the common over alert, stage I 
HIE to the rare, flaccid unresponsive ventilated baby in stage III. Convulsions may occur and jitteriness 
persists for days.
INVESTIGATIONS
Chest X-ray
The chest radiographs shows coarse, irregular pulmonary densities with areas of diminished aeration or 
consolidation2. Pneumothorax and pneumomediastinum are common in infants with severe meconium 
aspiration syndrome. Hyperinflation of the chest and flattening of the diaphragm are sometimes noted 
on radiograph. Cardiomegaly also might be detected, possibly as a manifestation of the underlying 
perinatal hypoxia.
ECG, ECHO
In uncomplicated MAS, both will be normal. If associated with severe intrapartum asphyxia there may 
be ECG changes suggesting subendocardial ischemia and the echocardiogram will show reduced 
cardiac contractility in those going to develop PPHN, changes in the systolic time interval will be seen 
on M-Mode echocardiography.
Blood Gases
Arterial blood gases characteristically reveal hyopoxemia with evidence of right to left shunting. 
Hyperventilation can result in respiratory alkalosis, although infants with severe disease usually have 
combined respiratory and metabolic acidosis secondary to hypoxia and respiratory failure.
PREVENTION OF PASSAGE OF MECONIUM IN UTERO
Mothers at risk for uteroplacental insufficiency include those with preeclampsia or increased blood 
pressure, chronic respiratory or cardiovascular disease, poor uterine growth, post term pregnancy. 
These women should be carefully monitored during pregnancy and the fetal heart rate should be 
monitored during labour, with fetal scalp blood samples obtained for pH determination when 
indicated6.
PREVENTION OF MECONIUM ASPIRATION PNEUMONIA
American Academy of Pediatrics/American College of Obstetrics and Gynecology guidelines 
recommend that when meconium of any consistency is present intrapartum, the obstetrician should 
clear the infant’s nose and oropharynx before delivery of the shoulders or chest. This can be done with 
either a bulb syringe or a DeLee suction catheter, which are equally effective10.
During the initial assessment at a delivery complicated by meconium, the pediatrician should determine 
whether  the infant is vigorous, demonstrated by heart rate >100 beats per minute, spontaneous 
respirations, and good tone (spontaneous movement or some degree of flexion). If the infant appears 
vigorous, routine care should be provided, regardless of the consistency of the meconium10. If 
respiratory distress develops or the infant becomes depressed, the trachea should be intubated under the 
direct laryngoscopy and intratracheal suctioning performed. In questionable cases, it is safer to intubate 
and suction, as MAS can occur in infants delivered through thinly stained amniotic fluid17.
Tracheal suctioning should be performed using an appropriately sized endotrocheal tube and a large 
bore meconium aspirator. In the presence of severe asphyxia, it may not be possible to clean the trachea 
of all meconium, and clinical judgment must be used to determine the amount of suctioning. However, 
meconium aspiration syndrome continues to occur in infants who are adequately suctioned in the 
delivery room. Aspiration of meconium or amniotic fluid inutero probably occurs in some with MAS, 
particularly in those with perinatal asphyxia. Studies have found that 7% to 10% of meconium – 
stained infants had meconium in their tracheas even when there was not any meconium visible at the 
vocal cords. 
ANTENATAL THERAPIES
Amnioinfusion
The use of transcervical amnioinfusion with normal saline solution in women whose labor is 
complicated by meconium stained amniotic fluid and repetitive fetal heart rate decelerations may 
reduce the incidence of meconium aspiration7. The rationale behind amnioinfusion is that by increasing 
the liquor volume, meconium will be diluted. In addition, in cases of oligohydramnios, the increased 
volume will prevent cord compression, subsequent hypoxia, fetal gasping and passage of meconium. 
However, the use of amnioinfusion requires further evaluation, as the therapy is associated with a 
number of complications, including a higher incidence of instrumental delivery and endometritis.
Timing and mode of delivery
In pregnancies that continue past the due date, induction as early as 41 weeks may help prevent MAS 
by avoiding passage of meconium. Delivery mode does not appear to significantly impact the risk of 
aspiration. Although most studies suggest that infants with MAS are more likely to be delivered by 
caesarean section than by vaginal delivery, this is largely due to suspicion or confirmation of fetal 
compromise. There is currently no evidence to suggest that MAS would be prevented by elective 
delivery by caesarean section of infants with meconium stained liquor.
MANAGEMENT OF MAS
The aim of treatment is to support the baby until his alveolar macrophages clear the debris and lung 
function returns to normal. Treatment consists of.
1. Conventional management & 
2. Non conventional management.
Conventional management consists of oxygen, mechanical ventilation, and fluid/nutritional support14.
Non conventional management consists of high frequency ventilation (HFV), exogenous surfactant, 
inhaled nitric oxide, liquid ventilation, and extracorporeal membrane oxygenation (ECMO)14.
OXYGEN
The administration of oxygen is critically important in infants with MAS and in many infants is the 
only respiratory therapy needed. The pulmonary vasculature in the term infants is exquisitely sensitive 
to oxygen tension, and failure to overcome hypoxaemia almost inevitably will lead to progressive 
pulmonary hypertention. Oxygen should be administrated early and liberally in any baby suspected of 
having inhaled meconium. The suggested target range of oxygen saturation is 94-98%; target PaO2 
60-90 mmHg.
NASAL CPAP
CPAP at pressure of 4-7 cmH2O may increase the PaO2 in babies with MAS. However, it is likely to 
increase the risk of pneumothorax in a disease characterized by air trapping, and the use of a nasal 
prong in a term neonates usually makes them irritable and restless, with a fall in PaO2.
INTUBATION & POSITIVE PRESSURE VENTILATION
INDICATIONS
Persistent hypoxaemia (SaO2<90%, PaO2<50%) in 100% oxygen, respiratory acidosis with pH<7.2011.
METHOD
Infants with MAS are frequently very difficult to manage once intubated and often require high peak 
inspiratory pressure (30-35cmH2O) to achieve gas exchange. Most evidence favours a high positive end 
expiratory pressure (6-8cm H2O) and a long expiratory time. The latter can be achieved using 
ventilatory rates of 40-60 breaths per minute, with an inspiratory time of 0.5-0.6 seconds11. When there 
is concomitant pulmonary hypertension, deep sedation should be maintained after intubation and 
muscle relaxation should be continued if the disease is severe.
GENERAL SUPPORTIVE CARE
It includes cardiovascular support such as volume and inotrope therapy, fluid restriction, IV therapy 
and nil orally until the respiratory distress is settled.
ANTIBIOTICS
Differentiating between bacterial pnenumonia and meconium aspiration by clinical course and chest x-
ray findings may be difficult. Although few infants with MAS have documented infections, the use of 
broad spectrum antibiotics (eg. Ampicillin and gentamycin) is usually indicated in infants when an 
infiltrate is seen on chest radiograph14.
HFV
The most commonly used methods of HFV are high frequency oscillatory ventilation and high 
frequency jet ventilation. No clinical trials have demonstrated benefits of either type of HFV compared 
to conventional therapy.
SURFACTANT
Because of meconium associated surfactant dysfunction, it would seem logical that use of exogenous 
surfactant could benefit babies with MAS. To date, only the small trial of Findlay et al  has assessed 
such therapy in babies with MAS in randomized controlled trial. They found exogenous surfactant to 
be benefit. However, they used one and a half times the standard surfactant dose which was not 
administrated in a bolus, but via a low infusion over 20 minutes15.
NITRIC OXIDE
Over the last 2 years, several large investigations have assessed the use of inhaled nitric oxide in the 
management of respiratory failure in newborn infants . Approximately half of the infants in these trials 
had MAS as their principal respiratory disorder. But NO has not shown to be superior to conventional 
therapy in preventing death or the need for ECMO16.
ECMO
It remains the therapy of last resort for MAS. Infants with MAS make up the most common diagnostic 
category of those treated with ECMO (36%) and have the highest survival rate of all ECMO treated 
babies. But there is relatively high associated morbidity with this therapy, which most commonly 
involves venoarterial cardiopulmonary byepass, ultimately necessitating ligation of right carotid 
artery19.
Thus this therapy should not be taken lightly and should still be reserved only for those infants who 
have a high likelihood of death without ECMO.
LONG TERM SEQUELE
1. MSAF by itself does not predict cerebral palsy. The overall incidence is 2 in 1000 live births 
.Finding of meconium alone does not prove that the infant experienced a degree of asphyxia sufficient 
for later neurologic abnormality. However MSAF with low APGAR (0-3) subsequently developed 
cerebral palsy in 9.4%13.
2. Long term pulmonary function testing at, 6 to 11 years after birth revealed large components of 
obstructive airway disease like spontaneous wheezing, exercise induced bronchospasm suggesting 
small airway injury and diseases in up to 40%. Chronic lung disease is relatively uncommon, occurring 
in only 5% of ventilated infants.
3. Infants who have undergone ECMO that is who have typically needed the greatest amount of 
ventilatory support to survive, it is the barotrauma and high O2 requirement likely contribute to the 
development of lung disease.
LITERATURE REVIEW
Wong SF, et al., in a retrospective study at Kowloon Hong Kong in July 1996 - June 1999 studied the 
relative risk of ‘fetal distress’ in pregnancy associated with meconium stained liquor at different 
gestations. Total of 9542 singleton pregnancies, delivered in a tertiary obstetric unit in Hong Kong 
were included in the study. They attempted to quantify the relative risk of non-reassuring CTG or fetal 
distress in pregnant women complicated by MSAF for preterm, term and post term deliveries. 20.4% 
identified as having meconium stained liquor, ranging from thin to thick staining. There was a strong 
association between incidence of meconium stained liquor (P < 0.0005) and moderate / thick 
meconium stained liquir with advanced gestational age. The incidence of non-reassuring CTG in 
women presenting with meconium stained liquor was significantly higher (9.8% Vs. 6.4%). The 
relative risk of non-reassuring CTG in women with meconium stained liquor increased with more 
advanced gestation. Premature labour was associated with higher incidence of fetal distress but the 
presence of meconium did not pose an additional risk20.
Zhu L, et al in a Cohort Study at Beijing, China in Feb. 2003 to study the epidemiology of meconium 
stained amniotic fluid on hospital basis. 6206 deliveries were divided into meconium stained amniotic 
fluid and normal amniotic fluid groups. Incidence of MSAF was 16.4%. There was no significant 
difference on maternal medical complications between two groups.  The average APGAR score in 
meconium stained group was lower than that in normal group (P=0.001). Relative factors on meconium 
stained fluid were maternal parity, gestational weeks > 42 weeks and large gestional age babies. 
Morbidity of newborn with MSAF was higher21.
Alchalabi H, et al in a prospective study between May 1997 to September 1997 at Princess Badea 
Teaching Hospital, Irbid to explore details of clinical relationship between MSAF in labour, abnormal 
fetal heart pattern and meconium aspiration. Incidence of MSAF was 8.5%. LSCS incidence was 
10.5%, indication being fetal distress which was diagnosed by abnormal fetal heart rate pattern. Many 
infants in MSAF group had a low Apgar score and required ventilation at birth. 
5% developed meconium aspiration with a mortality of 15.6%. There was an association between 
MSAF, abnormal FHR pattern in labour and a low Apgar score which should be considered a high risk 
situation. They concluded that meconium aspiration a problem that occurs with particulate meconium 
was significantly related to abnormal fetal heart rate pattern and longer length of labour22.
Berkers MD, et al., in a cohort study at University of Texas Health Science Centre at San Antonio in 
July 1994, to determine the risk of adverse neonatal outcome associated with MSAF independent to 
antepartum and intrapartum abnormalities. 2200 consecutive deliveries were examined and FHR 
tracings analyzed independently. Thick MSAF increased the risk of adverse outcome in more than 
three fold (RR 3.2, 95% confidence interval 2.0 - 5.2). This was independent of FHR tracing 
abnormalities or maternal hypertension, kidney or heart disease. They concluded that thick meconium 
alone should alert the physician to a high risk fetal condition23.
Gupta V, et al., in a prospective study at Banaras Hindu University, Varanasi in April 1996 to find out 
antenatal, intra partum and neonatal attributes in MSAF. 1426 live births occurring in 1500 consecutive 
deliveries over 1 year period were studied. Incidence of MSAF  was 14.3%. Thick meconium 69.11%. 
Hepatitis in mother, fetal distress during labour and IUGR were significant factors associated with 
MSAF. Consistency of meconium had direct bearing on neonatal outcome. Severe birth asphyxia 
occurred in 27% with thick meconium and 6.3% with thin meconium. MAS was observed in 6.38%. 
All deaths occurred in thick meconium group and were associated with SGA3.
Sheiner E, et al., in a prospective study at Faculty of Health Sciences, Scroka University Medical 
Centre, Israel in Jan 2002 to find out the effect of meconium on perinatal outcome.  They compared 
perinatal outcome of parturients with thick and thin MSAF to those with clear AF. The rate of MSAF 
was 18.1%. Thin meconium - 13.3%. Thick meconium - 4.8%. The rate of oligohydromnios was 
significantly higher among pregnancies complicated with thick meconium. (OR 7.2, 95% CI), 2.1-24.1; 
P=0.002). A statistically significantly higher risk for neonatal intensive care unit admission was 
observed among patients with thick meconium as compared to those with clear amniotic fluid 
(p=0.006), even after adjustment for oligohydromonios and abnormal fetal heart rate patterns. 
Therefore, concluded that thick MSAF should be considered a marker for possible fetal compromise, 
and lead to careful evaluation of fetal well-being24.
Greenwood, et al., in a prospective study at Dublin, Ireland in July 2003 to examine the incidence of 
meconium that which have only been passed intrapartum and to determine its neonatal associations and 
whether its absence is a useful sign. 8394 low risk laboring women at term with clear amniotic fluid at 
early amniotomy were studied. Meconium was passed in 5.2% of labour but was not detected until 
delivery of the fetal head in 51.5%. It was associated with moderate - severe acidosis, low Apgar score 
at 5 minutes and neonatal seizures. However, the sensitivity for these outcomes of the intrapartum 
passage of meconium and particularly its detection before delivery was very poor. Although correlated 
with adverse neonatal outcome, most affected infants had clear amniotic fluid throughout labour. The 
presence of clear amniotic fluid is an unreliable sign of fetal well being25.
David AN, et al., conducted a prospective study at Nigerian University Teaching Hospital during 
March-June 2003 to find out incidence and factors associated with meconium staining of the amniotic 
fluid. The incidence of MSAF was 20.4%. The rate increased with gestational age. No case was found 
below 37 weeks (p = 0.001). Primi parity, PROM, obstructed labour were more often associated with 
MSAF26. 
Gonzalez De Dios J did  a retrospective study at Department of Pediatrics, Hospital Universitario San 
Juan, Alicante in Jan 1998 to find out the neonatal morbidity associated with meconial amniotic fluid. 
The incidence of MSAF in all of the deliveries during 4 year period were studied. Associated morbidity 
in newborns with MSAF admitted in NICU and perinatal differences between newborns with thin Vs. 
thick MSAF were compared. Incidence of MSAF was 18%. Thin meconium - 10.8%. Thick meconium 
- 2.8%. Neonatal morbidities associated with MSAF were perinatal asphyxia in 56.1%, pulmonary 
pathology in 34% (MAS in 32 cases and other respiratory abnormalities in 43) and gastrointestinal 
pathology in 30.5% (transitory feeding intolerance in all cases).
They concluded that although the relationship between MSAF and perinatal asphyxia was 
controversial, their association increases neonatal morbidity. Thick meconium was implicated as a risk 
factor influencing the well being during the intrapartrum and post partum periods27.
Ziadesh SM, et al., in a prospective study at Jordan University of Science and Technology, Amman 
during April-November 1999 evaluated MSAF in term of fetal distress, MAS, perinatal morbidity and 
mortality. Women with a singleton cephalic pregnancy of completed 37-42 weeks and with no pre-
defined risk factor were recruited into the study. 390 patients with MSAF and 400 patients as controls 
without meconium stained were studied. Perinatal mortality increased from 2 per 1000 births with clear 
AF to 10 per 1000 with meconium (p<0.001). Delivery by caesarean section also increased with 
meconium from 
7-14% (p<0.001). They observed that women with thin meconium in the presence of normal fetal heart 
rate can be safely managed at the clinical level. Moderate thick meconium alone should alert the 
obstetrician to a high risk fetal conditions. Continuous FHR monitoring during labour and reassurance 
of fetal well being by acid-base assessment were most significant factors in the reduction of MAS28. 
STUDY JUSTIFICATION
A major goal of obstetric care is to prevent fetal morbidity and to bring down mortality as low as 
possible. This involves the early identification of the markers of fetal distress. The classical signs or 
markers of fetal hypoxia are variations in fetal heart rate pattern, presence of meconium in amniotic 
fluid, decrease in scalp pH, presence of intrapartum moulding, sudden increase or loss of fetal 
movements. Among the above mentioned traditionally, the fetal heart variation and meconium staining 
of amniotic fluid have been accepted as the most classical indicators of fetal distress. The appearance 
of meconium during labour has long been considered as a clinical sign of fetal distress. According to 
the classical conception, this is an indirect sign representing the response of the fetal gastro intestinal 
tract to hypoxic conditions.
Lately, the appearance of meconium as a sign of fetal distress has been questioned. Yet meconium 
aspiration is a severe life threatening illness in the neonate and need a good understanding of the 
circumstances under which this events occurs.
In light of the many controversial aspects, this study was undertaken to determine whether MSAF had 
influence on neonatal outcome.
AIM OF THE STUDY
a. To find out the immediate clinical outcome of new borns with meconium stained 
amniotic fluid.
b. Factors responsible for meconium stained amniotic fluid.
SUBJECTS AND METHODS
METHODOLOGY:
Study design: Case control study
Study place: Labour ward, Postnatal ward, New Born Unit, Maternity Hospital, 
Egmore, Chennai  
Study period: March 2005 - October 2006
Study Population: Cases include newborns delivered with meconium staining of amniotic 
fluid.
Foe each case, two controls will be taken. These are new borns who did not have MSAF or 
otherwise having clear amniotic fluid.
Sample size: 217
Maneuver
• Newborns who had meconium staining of the amniotic fluid were taken in to the study.
• Gestational weeks of the baby noted in terms of term, preterm or post term pregnancy.
• In case of preterm baby, modified Ballord’s score was determined.
• In case of term/SGA babies, ponderal index was calculated, depending upon which classified into symmetrical 
or asymmetrical IUGR.
• Mode of delivery of baby noted, whether is a labour naturalis, emergency or elective LSCS or via forceps 
delivery.
• If delivered through LSCS, indication for LSCS was noted.
• Antenatal USG if done noted, with particular mention to amniotic fluid index whether had oliogohydromnios 
or not.
• Placenta is examined for calcifications.
• Intrapartum fetal monitoring (CTG) if done was noted for any fetal heart rate variability.
• Grading of meconium done either as thin or thick meconium.
• Type of baby noted as either vigorous or non vigorous baby.
• Type of resuscitation done for these babies are noted in terms of routine initial steps of resuscitation or 
required tracheal toileting, bag mask ventilation or intubation.
• One minute and five minute Apgar determined.
• Those babies who were not admitted were followed up in the postnatal wards for 3 days. During each visit, 
respiratory rate, heart rate, feeding difficulties if any noted.
• Those who are admitted in new born unit were followed up till discharge.
• During hospital stay, Downe’s score given till the respiratory distress settled, and hours of settlement of 
respiratory distress noted.
• Type of management of these babies entered whether required oxygen, oxygen with IVF, oxygen, IVF with 
antibiotics, and anticonvulsants or required mechanical ventilation.
• CXR taken in all babies who were admitted. Repeat CXR are also taken if indicated.
• Outcome like seizures, airleak, MAS etc., were looked for.
• For each MSAF baby, two newborn without MSAF were recruited and looked for maternal risk factors and 
fetal risk factors. These include maternal risks such as PIH, APH, anaemia, heart disease, gestational diabetes, 
maternal malnutrition, jaundice complicating pregnancies, fetal factors include IUGR, post dated babies etc.,
STATISTICAL ANALYSIS
To study the factors associated with MSAF, OR (95% CI) was arrived by univariate analysis. To adjust 
for the confounders multivariate analysis was done to arrive at adjusted OR (95% CI).
OBSERVATION
Total No of cases : 217 
Table 1: 
Incidence of Type of meconium
Type of meconium n %
Thin 141 64.97%
Thick 76 35.02%
Incidence of MSAF is 16.9%. Among 217 cases of MSAF, thin meconium constituted 141 cases 
(64.97%) and thick meconium 76 cases (35.02%). Incidence of thin meconium is more when compared 
to thick meconium.
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Table - 2
Type of Babies in MSAF
Type of Baby N %
Type of meconium
Thin Thick
n % n %
P value
Vigorous 170 78.7 127 74.7 43 25.3
Non vigorous 47 21.65 14 29.78 33 70.21
0.00
Of the 217 cases of meconium stained liquor, 170 (78.7%) cases are vigorous babies and 47 (21.6%) 
are nonvigorus. Out of 47 babies who were non vigorous, most of them (70.2%) had thick meconium 
stained liquor when compared to 25.3% among vigorous babies. So thick meconium stained amniotic 
fluid was more common among non vigorous babies. This was found to be statistically significant 
(Table 2; p=0.00)
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Table - 3
Incidence of MSAF with respect to gender
Sex of Baby N %
Type of meconium
Thin Thick
n % n %
P value
Male 108 49.76 75 69.4 33 30.6
Female 109 50.23 66 60.55 43 39.44
0.20
In the meconium stained liquor, 108 (49.76%)  are male and 109(50.23%) are female, almost in the 
ratio of 1:1. Among 108 male babies, 75 babies (69.4%) are associated with thin meconium staining 
and 
33 (30.6%) with thick meconium staining. Among 109 female babies, 66(60.55%) are with thin 
meconium when compared to 43 (39.44%) babies who are with thick meconium staining. P value is 
0.20 which is statistically not significant (Table - 3; p = 0.20)
Table - 4
Age of the mother & meconium stained amniotic fluid
Age of mother N %
Type of meconium
Thin Thick
n % n %
P value
<20 years 48 22.2 34 70.8 14 29.2
20-35 years 154 70.8 96 62.1 58 37.9
>35 years 15 6.9 11 73.3 4 26.7
0.42
Out of 217 cases of meconium staining, 48 cases (22.2%) occurred in age group of mothers less than 20 
years. Out of which 34 (70.8%) babies presented with thin meconium staining and 14  babies (29.2%) 
with thick meconium staining. 154 cases occurred in age group of mothers between 20-35 years, out of 
which 96 (62.1%) are thin meconium and 58 cases (37.9%) are thick meconium stained. There are 15 
cases of meconium, occurred in age group more than 35 years. Out of which 11 cases (73.3%) are thin 
meconium and 4 (26.7%) are thick meconium. In all the age groups thin meconium staining 
predominant reflecting the general trend. P value is 0.42, which is statistically not significant (Table 4; 
p = 0.42).
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Table - 5
Antenatal risks in MSAF
Antenatal risks N %
Type of meconium
Thin Thick
n % n %
P value
PIH 41 19.0 20 48.8 21 51.2
Anaemia 13 6.0 8 61.5 5 38.5
GDM 3 1.4 3 100.0 0 0.0
CVS 1 0.5 0 0.0 1 100.0
No risks 159 73.1 110 69.0 49 31.0
0.05
In MSAF, 41 cases (19.0%), had PIH as a complication in their mother. Of which 20 (48.8%) had thin 
meconium staining and 21 (51.2%) had thick meconium staining. 13 cases had anaemia as an antenatal 
risks, of which 8 (61.5%) had thin meconium and 5 (38.5%) had thick meconium. 3 cases had GDM as 
a complication and all the 3 (100%) had thin meconium staining.
Majority of MSAF, i.e., 159 cases (73.1%) had no antenatal risks, otherwise born to a normal mother, 
of which 110 cases (69.0%) are with thin meconium staining and 49 cases (31.0%) are with thick 
meconium staining.
Table - 6
Requirement of admission in MSAF babies
Admission N %
Type of meconium
Thin Thick
n % n %
P value
Yes 106 48.84 54 38.29 52 68.42
No 111 51.15 88 62.41 23 30.26
0.00
Of the 217 cases of MSAF, 106 cases (48.84%) required admission and 111 cases (51.15%) did not 
require admission. In thin MSAF, 88 (62.4%) did not require admission, whereas 54 (38.29%) needed 
admission. In thick MSAF 52 (68.42%) required admission and 23 (30.26%) did not require admission. 
Thus the admission rate is higher in thick meconium group. P value is 0.00, which is statistically 
significant (Table 6; p = 0.00)
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Table - 7
Type of resuscitation required in MSAF babies
Type of resuscitation N %
Type of meconium
Thin Thick
n % n %
P value
Routine 172 79.2 128 74.3 44 25.7
Tracheal toileting 21 9.7 8 38.1 13 61.9
Tracheal toileting with 
BMV
23 10.6 5 21.7 18 78.3
BTV 1 0.5 0 0.0 1 100.0
0.00
Of the 217 cases of MSAF, majority i.e., 172 cases (79.2%) required routine initial steps of 
resuscitation. 23 required tracheal toileting with BMV, 21 required tracheal toileting alone. One case 
(0.5%) required bag and tube ventilation. Routine, initial steps of resuscitation alone required in 128 
cases (74.3%) of thin meconium staining and 44 cases (25.7%) of thick meconium staining. Tracheal 
toileting needed in 13 (61.9%) cases of thick meconium stained liquor. BTV needed in 1 case (100%) 
of thick meconium staining. Tracheal toileting with BMV required in 18 cases (78.3%) of thick 
meconium liquor when compared to 5 cases (21.7%) of thin MSAF. P value is 0.00, which is 
statistically significant (Table 7; p = 0.00)
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Table - 8
X-ray findings in MSAF babies
Chest X-ray N %
Type of meconium
Thin Thick
n % n %
P value
Normal 81 76.5 47 58.02 34 41.97
MAS 20 18.9 4 20.0 16 80.0
Pneumothorax 6 5.7 3 50.0 3 50.0
0.01
81 cases (76.5%) had a normal x-ray. 20 cases (18.9%) had features of meconium aspiration. 6 cases 
(5.7%) had pneumothorax. Majority of normal x-rays i.e. 47 cases (58.02%) belong to thin MSAF. 
Meconium aspiration is found in 16 cases (80.0%) of thick meconium, when compared to 4 cases 
(20.0%) of thin meconium. Pneumothorax occurred equally in both the groups. P value is 0.01, which 
is statistically significant (Table - 8; p = 0.01).
Table - 9
Settlement of RD in MSAF babies
Hours of settlement of 
Resp. distress N %
Type of meconium
Thin Thick
n % n %
P value
<6 hours 66 61.3 42 63.1 24 36.9
6 - 24 hours 20 18.9 8 40.0 12 60.0
24 - 48 hours 6 5.7 1 16.7 5 83.3
48-72 hours 1 0.9 0 0 1 100.0
> 3 days 4 3.8 1 25.0 3 75.0
Resp. failure 10 9.4 2 20.0 8 80.0
0.02
In majority of the cases, 66 (61.3%) respiratory distress settled within 6 hours of admission. In 20 cases 
(18.9%) distress settled between 6 hours - 24 hours. 10 cases (9.4%) present with respiratory failure. 
Respiratory distress settled within 6 hours in 42 cases (63.1%) of thin meconium stained liquor when 
compared to 24 cases (36.9%) of thick meconium stained liquor. Those who presented with respiratory 
failure, majority i.e., 8 cases (80.0%) had thick MSAF and only 2 cases (20%) had thin MSAF. 
Respiratory distress took more time to come down among who had thick meconium stained liquor 
when compared to those who had thin meconium stained. This was found to be significant statistically 
(Table 9; p = 0.02)
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Table - 10
Type of management required in MSAF babies
Type of management N %
Type of meconium
Thin Thick
n % n %
P value
O2 with IVF 42 39.25 30 71.42 12 29.3
O2 with IVF, AB 22 20.8 7 31.8 15 68.2
O2 with IVF, AB, ACT 33 31.1 15 45.5 18 54.5
Ventilator 10 9.4 2 20.0 8 80.0
0.003
42 cases (39.25%) required O2 with IVF. 33 cases (31.1%) required O2 , IVF, antibiotics with anti-
convulsants, of which 18 cases (54.5%) are thick MSAF and 15 cases (45.5%) are thin MSAF. 10 cases 
(9.4%) required mechanical ventilation, of which 8 cases (80%) are thick MSAF and 2 cases (20%) are 
thin MSAF. Thus, mechanical ventilation required more in thick MSAF when compared to thin MSAF. 
O2 , IVF, antibiotics are required in 15 cases (68.2%) of thick MSAF and 7 cases (31.8%) of thin 
MSAF. P value is 0.003, which is statistically significant (Table 10; p = 0.003).
Table - 11
Outcome of babies delivered through MSAF
Outcome N %
Type of meconium
Thin Thick
n % n %
P value
Seizures 34 32.1 16 47.1 18 52.9
Meconium aspiration 5 4.7 1 20.0 4 80.0
Air leak 5 4.7 2 40.0 3 60.0
Death 10 9.4 2 20.0 8 80.0
Normal 53 49.53 33 62.26 20 37.73
0.08
Out come of MSAF was normal in 53 cases (49.1%), seizures seen in 34 cases (32.1%), meconium 
aspiration in 5 cases (4.7%), Airleak in 5 cases (4.7%) and death in 10 cases (9.4%). Among seizure 
group there were higher proportion of babies born with thick meconium stained liquor.  Similarly in other 
outcomes like meconium aspiration, airleak and death, there were higher proportions of babies with 
thick meconium staining when compared to thin meconium staining. So, thick MSAF indicates a high 
risk fetal condition. P value is 0.08 which is statistically insignificant (Table 11; p = 0.08)
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COMPARISON OF MATERNAL & FETAL FACTORS AMONG NEWBORNS WITH 
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Table - 12
Parity and its association with MSAF
Parity N %
MSAF Non MSAF
n % n %
OR 95% CI P Value
Primi 367 55.7 146 67.28 221 50 3.1 2.1, 4.7
Multi 
gravidae 74 11.2 33 15.20 41 9.2 3.8 2.1, 6.8
II gravidae 218 33.1 38 17.51 180 40.72 1.0 Ref.
0.00
In the meconium stained group 146 cases (67.28%) are primigravidae, 33 cases (15.20%) are 
multigravidae. In non-MSAF group 221 cases (50%) are primi gravidae and 180 cases (40.72%) are II 
gravidae. Odds of newborns with MSAF being born to multigravidae is 3.8 when compared to those 
who did not have MSAF. [OR (95% CI) = 3.8 (2.1,6.8)]. Odds of newborns with MSAF being born to 
primi gravidae is 3.1 when compared to those who did not have MSAF [OR (95% CI) = 3.1 (2.1,4.7)].
Table - 13
Antenatal risk in 2 groups
Antenatal risk N %
MSAF Non MSAF
n % n %
OR 95% CI P Value
PIH 60 9.1 42 70.0 18 20.0 6.1 3.4,11
Anaemia 18 2.7 13 72.2 5 27.8 6.9 2.4, 19.5
Nil 574 87.2 158 27.5 416 72.5 1.0 Ref.
0.00
There are 60 cases of PIH, of which 42 (70.0%) are associated with meconium stained liquor and 18 
(30%) are associated with clear liquor. There are 18 cases of anaemia, 13 of which (72.2%) belong to 
MSAF group and 5 (27.8%) to non-MSAF group. PIH as antenatal risk occurred in 42 cases (70.0%) of 
MSAF and 18 cases (20.0%) of non MSAF group. Anaemia occurred in 13 cases (72.2%) of MSAF 
group when compared to 5 cases (27.8%) of non MSAF group. 
Odds of newborns with MSAF having anaemia as a complication antenatally in mothers is 6.9 when 
compared to non-MSAF [OR (95% CI) = 6.9 (2.4,19.5)]. Odds of newborns with MSAF having PIH as 
a complication antenatally in mother is 6.1 when compared to non-MSAF [OR (95% CI) = 6.1 
(3.4,11)]. 
Table - 14
Mode of deliveries in 2 groups
Mode of 
delivery N %
MSAF Non MSAF
n % n %
OR 95% CI P Value
Emergency 
LSCS 388 58.9 166 42.8 222 57.2 3.2 2.2, 4.6
Labour 
naturalis 271 41.1 51 18.8 220 81.2 1.0 Ref
0.00
Emergency LSCS as a mode of delivery is seen in 166 (42.8%) cases of meconium stained liquor and 
in 222 (57.2%) cases of non- meconium stained liquor. Majority of MSAF 166 cases (76.49%) were 
delivered through emergency LSCS and only 51 (23.50%) were born through labour naturalis. Whereas 
in non MSAF group the mode of delivery being emergency LSCS or labour naturalis are equal.
Odds of newborns with MSAF being delivered through emergency LSCS is 3.2 when compared to 
those who did not have MSAF [OR (95% CI) = 3.2 (2,2, 4.6)]
Table - 15
Indication of LSCS in 2 groups
Indication 
of LSCS N %
MSAF Non MSAF
n % n %
OR 95% CI P Value
Previous 
LSCS with 
FD
33 8.4 24 15.48 9 4.22 9.9 4.2, 23.7
Fetal 
distress 117 29.8 75 48.38 42 19.71 6.7 3.8, 11.6
CPD 81 20.7 27 17.41 54 25.35 1.9 1.0, 3.5
Previous 
LSCS 137 34.9 29 18.70 108 50.70 1.0 Ref
0.00
Majority of indication for LSCS in MSAF is FD reported in 75 cases (48.38%). In 27 cases (17.41%), 
the indication for LSCS is CPD and in 24 cases (15.48%) previous LSCS with fetal distress.
Odds of newborns in MSAF delivered two emergencies LSCS indication being previous LSCS with 
fetal distress is 9.9 when compared to newborns without MSAF [OR (95% CI) = 9.9 (4.2, 23.7)].
Odds of newborns in MSAF delivered two emergencies LSCS indication being fetal distress is 6.7 
when compared to newborns without MSAF [OR (95% CI) = 6.7 (3.8, 11.6)].
Table - 16
Placental Calcification in 2 groups
Placental  
calcification N %
MSAF Non MSAF
n % n %
OR 95% CI P Value
Yes 26 4.0 24 92.3 2 7.7 27.4 6.5,11.6
No 630 96.0 190 30.2 440 69.8 1.0 Ref.
0.00
Placental calcification seen in 26  cases (4.0%) of which 24 cases (92.3%) are with MSAF and only 2 
(7.7%) are without MSAF. Placental calcification which denotes placental insufficiency are more in 
MSAF group. 
Odds of newborn with MSAF having placental calcification is 27.4 when compared to babies born to 
non MSAF [OR (95% CI) = 27.4 (6.5, 11.6)].
Table - 17
Association of IUGR in MSAF
Growth 
Retardation N %
MSAF Non MSAF
N % n %
OR 95% CI P Value
SGA 
(Asymmetrical 
IUGR)
33 5.0 27 81.8 6 18.2 10.5 4.3,25.8
AGA 623 94.5 187 30.0 436 70.0 1.0 Ref.
0.00
Out of the 33 SGA babies (asymmetrical IUGR) 27 cases (81.8%) occurred in MSAF group and 6 
cases (18.2%) in non-MSAF group. Hence incidence of IUGR is more in MSAF.
Odds of newborn with MSAF, being small for gestational age (asymmetric IUGR) is 10.5 when 
compared to those who did not have meconium stained amniotic fluid. [OR (95% CI) = 10.5 (4.3, 
25.8)].
Among the factors which are analysed,
Primigravidae [OR (95% CI) = 2.1 (1.4, 3.4)]
Multigravidae [OR (95% CI) = 2.1 (1.1, 4.1)]
PIH [OR (95% CI) = 4.4 (2.2, 8.5)]
Anaemia [OR (95% CI) = 5.1 (1.6, 16.6)] and
CTG with fetal heart variability [OR (95% CI) = 4.5 (2.8, 7.3)]
are the factors which are found to be independently associated with meconium staining of aminiotic 
fluid.
DISCUSSION
• In our study, with respect to parity of mother the meconium stained amniotic fluid had 146 (67.28%) cases of 
primigravidae when compared to multigravidae (15.20%) and II gravidae. Thus primi parity is associated to 
MSAF, which is similar to the study conducted by David et al26. Incidence of primi is higher in our study when 
compared to the study of Narang et, where the incidence was 57.14% in primi and 42.86% in multigravidae5.
• Majority of MSAF are delivered through emergency LSCS in our study with 76.49% incidence. This indicates 
that majority of MSAF are being delivered through caesarean section which is similar to the study of Wong et 
al20.
• In our present study the major indication for LSCS in MSAF group is fetal distress, which being reported in 75 
cases (48.38%). This is higher when compared to the study of Alchalabi et al, where the indication of LSCS 
for fetal distress was only 10.5%22.
• There is no antenatal risk in 158 cases (74.17%) in meconium stained group. 42 cases (19.71%) had PIH as an 
antenatal risks and anaemia in 13 cases (6.10%). This is similar to the study of Kanula et al., where PIH was 
the main antepartum complication leading to meconium stained liquor. Other factors like hepatitis in mother, 
asthma, APH which were significant in their study was not so in our study. This is contrast to the study of Zhu 
et al., whom concluded that there is no correlation between MSAF and maternal medical complication21.
• Significant fetal heart rate variability in meconium stained group is observed which is similar to the study of 
Sheiner et al., where they found a significant linear association between meconium stained amniotic fluid and 
abnormal fetal heart rate24.
• Majority showed placental calcification in meconium stained group. This is found to be significant in our 
study and no previous study mentioned this as a factor in MSAF.
• Though it was mentioned in the study of Berkus et al., that males had a preponderance of getting meconium 
stained liquor23, in our present study both male and female had equal change of getting MSAF., But when the 
consistency is considered, 75 cases (69.4%) of thin meconium are male and 43 cases (56.5%) of thick 
meconium are female.
• In our present study, majority of meconium stained liquor are term babies with 215 cases (99.07%) and 2 
(0.01%) are post-term and no preterm babies. This is in contrast with Zhu et al study, where they concluded 
that the relative factors on MSAF were gestational weeks >42 weeks and large for gestational age babies21.
• In our study, out of 33 cases of SGA, 27 (81.8%) had MSAF. All of them are asymmetrical IUGR babies. 
Thus the IUGR babies had a higher incidence of MSAF when compared to AGA babies. This is comparable to 
previous study of Gupta et al, where IUGR was also associated with MSAF3.
• In our study, thin meconium seen in 141 cases (64.8%) and thick meconium in 76 cases (35.2%). This is 
comparable to previous studies done by Sheiner E et al24, in which thin meconium out numbered the thick 
meconium.
• The morbidity associated with thick meconium is higher in our study. Out of 20 cases of meconium aspiration 
(detected by x-ray). 16 cases (80%) are with thick meconium and 4 cases (20%) in thin meconium.
• Among 10 cases who presented with respiratory failure, 8 cases (80%) had thick meconium staining and only 
2 (20%) with thin meconium. 18 cases (54.5%) of thick meconium required anticovulsants along with O2, IVF 
and antibiotics. The need for mechanical ventilation also high in thick meconium group. Out of 10 cases which 
needed mechanical ventilation 8 (80%) are associated with thick meconium and only 2 (20%) with thin 
meconium. Seizures, MAS, airleak are more observed in thick meconium group. Out of 10 death, 8 (80%) 
cases are with thick meconium. This morbidities with thick meconium are similar to the study of Sheiner et al., 
Gonzalez et al., where they concluded that consistency of meconium had a direct bearing on neonatal outcome 
and thick meconium alone should alert the physician to a high risk fetal condition27.
• Outcome of MSAF in our study is seizure in 32.1% MAS in 4.7%, Airleak in 4.7%, and death in 10% of cases. 
This is similar to the study of Manju Latha Sharma et al with seizures in 25.64%, airleak in 12.8% and death in 
10.25% cases29.
CONCLUSION
Meconium staining of amniotic fluid by itself has no significance. In our study, not all the babies who 
were born through meconium stained amniotic fluid required admission. Only a part of them required 
admission. Even in the admitted babies, respiratory distress settled within few hours of supportive 
measures of treatment. But, meconium stained amniotic fluid becomes a significant factor when 
associated with factors like maternal PIH, anaemia, oligohydromnios, IUGR babies, CTG showing 
FHR variability and placental calcifications. In these cases MSAF is associated with morbidity and 
mortality; majority of which are thick meconium suggesting that consistency of meconium had direct 
bearing in neonatal outcome. Although mode of delivery in MSAF does not prevent meconium 
aspiration, majority of them are delivered through caesarean section which is questionable.
PROFORMA
Name
Sex
Time/Date
Mother IP No
Address
Age
Height  
Weight
Hb%
Parity
Mode of Delivery
Indication for LSCS
USG Mother  
Fetal Heart Rate Monitoring (CTG)  
Antenatal Factors
Intrapartum Factors
Details of Baby
Term Preterm wks Post term wks
Birth Weight
IUGR Ponderal Index
Symmetrical
Asymmetrical
Type of Baby
Vigorous Non Vigorous
Type of resuscitation
Apgar at 1 mint
Apgar at 5 mints
Admission Yes No
Follow up in Postnatal wards
Cry Colour Activity HR RR Feeding Difficulties Others
Day 1
Day 2
Day 3
Discharged on - Day of Life
Investigations (for admitted babies)
Chest X-ray RPT-CXRS
CBG
USG - Cranium
Diagnosis
Follow up in NICU:
Days IVF O2 Antibiotics Seizures Anticonv RDS (Downe’s score)
Outcome
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